Challenging the status quo to improve the translational potential of preclinical oncology studies

The authors acknowledge funding from the European Union Horizon 2020 research and innovation program ‘GLIORESOLVE’ (grant agreement no. 101073386). Funding is further acknowledged from Science Foundation Ireland (grants 18/RI/5759, 20/FFP-P/8884 and 20/FFP-P/8613), the Irish Health Research Board (grants ILP-POR-2019-066 and ILP-POR-2022-007), the Irish Higher Education Authority North South Research Program ‘RADCOL’ and the Luxembourg National Research Fund (C20/BM/14646004/GLASSLUX). Additional financial support is acknowledged from the Beaumont Hospital, Dublin Foundation, Brain Tumour Ireland and a private research funding donation (to A.T.B.).

留言 (0)

沒有登入
gif